Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Edward Havranek to Heart Failure

This is a "connection" page, showing publications Edward Havranek has written about Heart Failure.

 
Connection Strength
  
 
 
2.456
  
  1. Havranek EP. Capturing complexity: socioeconomic disadvantage and heart failure outcomes. Circ Heart Fail. 2015 May; 8(3):413-4.
    View in: PubMed
    Score: 0.203
  2. Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, Masoudi FA, Magid DJ, Havranek EP. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011 Aug; 17(8):664-9.
    View in: PubMed
    Score: 0.155
  3. Havranek EP, Peterson PN. Are implanted defibrillators effective therapy in the elderly?: Asked, not answered. Circ Heart Fail. 2010 Jan; 3(1):4-6.
    View in: PubMed
    Score: 0.140
  4. Havranek EP, Allen LA. Listening to patients. J Am Coll Cardiol. 2008 Nov 18; 52(21):1709-10.
    View in: PubMed
    Score: 0.130
  5. Havranek EP. From black and white to shades of gray: race and renin-angiotensin system blockade. J Am Coll Cardiol. 2008 May 13; 51(19):1872-3.
    View in: PubMed
    Score: 0.125
  6. Riegel B, Moser DK, Powell M, Rector TS, Havranek EP. Nonpharmacologic care by heart failure experts. J Card Fail. 2006 Mar; 12(2):149-153.
    View in: PubMed
    Score: 0.107
  7. Havranek EP. Improving the outcomes of heart failure care: putting technology second. J Am Coll Cardiol. 2005 May 17; 45(10):1665-6.
    View in: PubMed
    Score: 0.102
  8. Hauptman PJ, Havranek EP. Integrating palliative care into heart failure care. Arch Intern Med. 2005 Feb 28; 165(4):374-8.
    View in: PubMed
    Score: 0.100
  9. Havranek EP, Simon TA, L'Italien G, Smitten A, Hauber AB, Chen R, Lapuerta P. The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail. 2004 Aug; 10(4):339-43.
    View in: PubMed
    Score: 0.096
  10. Havranek EP, Krumholz HM, Dudley RA, Adams K, Gregory D, Lampert S, Lindenfeld J, Massie BM, Pina I, Restaino S, Rich MW, Konstam MA. Aligning quality and payment for heart failure care: defining the challenges. J Card Fail. 2003 Aug; 9(4):251-4.
    View in: PubMed
    Score: 0.090
  11. Havranek EP, Masoudi FA, Rumsfeld JS, Steiner JF. A broader paradigm for understanding and treating heart failure. J Card Fail. 2003 Apr; 9(2):147-52.
    View in: PubMed
    Score: 0.088
  12. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J. 2002 Mar; 143(3):412-7.
    View in: PubMed
    Score: 0.081
  13. Bekelman DB, Allen LA, McBryde CF, Hattler B, Fairclough DL, Havranek EP, Turvey C, Meek PM. Effect of a Collaborative Care Intervention vs Usual Care on Health Status of Patients With Chronic Heart Failure: The CASA Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):511-519.
    View in: PubMed
    Score: 0.062
  14. Bekelman DB, Allen LA, Peterson J, Hattler B, Havranek EP, Fairclough DL, McBryde CF, Meek PM. Rationale and study design of a patient-centered intervention to improve health status in chronic heart failure: The Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) randomized trial. Contemp Clin Trials. 2016 11; 51:1-7.
    View in: PubMed
    Score: 0.056
  15. Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, Cook NR, Felker GM, Francis GS, Hauptman PJ, Havranek EP, Krumholz HM, Mancini D, Riegel B, Spertus JA. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012 Apr 17; 125(15):1928-52.
    View in: PubMed
    Score: 0.041
  16. Peterson PN, Campagna EJ, Maravi M, Allen LA, Bull S, Steiner JF, Havranek EP, Dickinson LM, Masoudi FA. Acculturation and outcomes among patients with heart failure. Circ Heart Fail. 2012 Mar 01; 5(2):160-6.
    View in: PubMed
    Score: 0.040
  17. Riegel B, Moser DK, Anker SD, Appel LJ, Dunbar SB, Grady KL, Gurvitz MZ, Havranek EP, Lee CS, Lindenfeld J, Peterson PN, Pressler SJ, Schocken DD, Whellan DJ. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation. 2009 Sep 22; 120(12):1141-63.
    View in: PubMed
    Score: 0.034
  18. Kosiborod M, Inzucchi SE, Spertus JA, Wang Y, Masoudi FA, Havranek EP, Krumholz HM. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation. 2009 Apr 14; 119(14):1899-907.
    View in: PubMed
    Score: 0.033
  19. Bekelman DB, Rumsfeld JS, Havranek EP, Yamashita TE, Hutt E, Gottlieb SH, Dy SM, Kutner JS. Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med. 2009 May; 24(5):592-8.
    View in: PubMed
    Score: 0.033
  20. Krantz MJ, Havranek EP, Haynes DK, Smith I, Bucher-Bartelson B, Long CS. Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study. J Card Fail. 2008 May; 14(4):303-9.
    View in: PubMed
    Score: 0.031
  21. Bekelman DB, Havranek EP, Becker DM, Kutner JS, Peterson PN, Wittstein IS, Gottlieb SH, Yamashita TE, Fairclough DL, Dy SM. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007 Oct; 13(8):643-8.
    View in: PubMed
    Score: 0.030
  22. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 Aug 14; 50(7):600-6.
    View in: PubMed
    Score: 0.030
  23. Rathore SS, Masoudi FA, Wang Y, Curtis JP, Foody JM, Havranek EP, Krumholz HM. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J. 2006 Aug; 152(2):371-8.
    View in: PubMed
    Score: 0.028
  24. Nallamothu BK, Payvar S, Wang Y, Kosiborod M, Masoudi FA, Havranek EP, Foody JM, Casscells SW, Krumholz HM. Admission body temperature and mortality in elderly patients hospitalized for heart failure. J Am Coll Cardiol. 2006 Jun 20; 47(12):2563-4.
    View in: PubMed
    Score: 0.027
  25. Foody JM, Shah R, Galusha D, Masoudi FA, Havranek EP, Krumholz HM. Statins and mortality among elderly patients hospitalized with heart failure. Circulation. 2006 Feb 28; 113(8):1086-92.
    View in: PubMed
    Score: 0.027
  26. Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, Conard MW, Williams RE. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006 Feb 21; 47(4):752-6.
    View in: PubMed
    Score: 0.027
  27. Ko DT, Tu JV, Masoudi FA, Wang Y, Havranek EP, Rathore SS, Newman AM, Donovan LR, Lee DS, Foody JM, Krumholz HM. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med. 2005 Nov 28; 165(21):2486-92.
    View in: PubMed
    Score: 0.026
  28. Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM, Havranek EP, Krumholz HM. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med. 2005 Oct 24; 165(19):2237-44.
    View in: PubMed
    Score: 0.026
  29. Masoudi FA, Baillie CA, Wang Y, Bradford WD, Steiner JF, Havranek EP, Foody JM, Krumholz HM. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005 Oct 10; 165(18):2069-76.
    View in: PubMed
    Score: 0.026
  30. Foody JM, Rathore SS, Wang Y, Herrin J, Masoudi FA, Havranek EP, Krumholz HM. Physician specialty and mortality among elderly patients hospitalized with heart failure. Am J Med. 2005 Oct; 118(10):1120-5.
    View in: PubMed
    Score: 0.026
  31. Masoudi FA, Wolfe P, Havranek EP, Rathore SS, Foody JM, Krumholz HM. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes. J Am Coll Cardiol. 2005 Sep 20; 46(6):955-62.
    View in: PubMed
    Score: 0.026
  32. Radford MJ, Arnold JM, Bennett SJ, Cinquegrani MP, Cleland JG, Havranek EP, Heidenreich PA, Rutherford JD, Spertus JA, Stevenson LW, Goff DC, Grover FL, Malenka DJ, Peterson ED, Redberg RF. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation. 2005 Sep 20; 112(12):1888-916.
    View in: PubMed
    Score: 0.026
  33. Luther SA, McCullough PA, Havranek EP, Rumsfeld JS, Jones PG, Heidenreich PA, Peterson ED, Rathore SS, Krumholz HM, Weintraub WS, Spertus JA, Masoudi FA. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail. 2005 Aug; 11(6):414-21.
    View in: PubMed
    Score: 0.026
  34. Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JM, Krumholz HM. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation. 2005 Jul 05; 112(1):39-47.
    View in: PubMed
    Score: 0.026
  35. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, Rathore SS, Krumholz HM. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation. 2005 Mar 15; 111(10):1270-7.
    View in: PubMed
    Score: 0.025
  36. Rathore SS, Foody JM, Wang Y, Herrin J, Masoudi FA, Havranek EP, Ordin DL, Krumholz HM. Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J. 2005 Jan; 149(1):121-8.
    View in: PubMed
    Score: 0.025
  37. Masoudi FA, Rumsfeld JS, Havranek EP, House JA, Peterson ED, Krumholz HM, Spertus JA. Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail. 2004 Oct; 10(5):368-73.
    View in: PubMed
    Score: 0.024
  38. Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, Krumholz HM. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation. 2004 Aug 10; 110(6):724-31.
    View in: PubMed
    Score: 0.024
  39. Hockensmith ML, Estacio RO, Mehler P, Havranek EP, Ecder ST, Lundgren RA, Schrier RW. Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes. J Card Fail. 2004 Apr; 10(2):126-31.
    View in: PubMed
    Score: 0.024
  40. Foody JM, Rathore SS, Wang Y, Herrin J, Masoudi FA, Havranek EP, Radford MJ, Krumholz HM. Predictors of cardiologist care for older patients hospitalized for heart failure. Am Heart J. 2004 Jan; 147(1):66-73.
    View in: PubMed
    Score: 0.023
  41. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, Spertus JA. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003 Nov 19; 42(10):1811-7.
    View in: PubMed
    Score: 0.023
  42. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003 Aug; 146(2):250-7.
    View in: PubMed
    Score: 0.022
  43. Masoudi FA, Wang Y, Inzucchi SE, Setaro JF, Havranek EP, Foody JM, Krumholz HM. Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA. 2003 Jul 02; 290(1):81-5.
    View in: PubMed
    Score: 0.022
  44. Rathore SS, Foody JM, Wang Y, Smith GL, Herrin J, Masoudi FA, Wolfe P, Havranek EP, Ordin DL, Krumholz HM. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA. 2003 May 21; 289(19):2517-24.
    View in: PubMed
    Score: 0.022
  45. Lindenfeld J, Fiske KS, Stevens BR, Debuhr J, Havranek EP, Abrams FR. Age, but not sex, influences the measurement of ejection fraction in elderly patients hospitalized for heart failure. J Card Fail. 2003 Apr; 9(2):100-6.
    View in: PubMed
    Score: 0.022
  46. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, Krumholz HM. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol. 2003 Jan 15; 41(2):217-23.
    View in: PubMed
    Score: 0.022
  47. Ramunno LD, French LL, O'Brien A, Ligor ML, Havranek EP, Taylor JP, Ordin DL. Improving heart failure care: CMS' initiative. Improving heart failure care in outpatient practices. Congest Heart Fail. 2002 Mar-Apr; 8(2):86-9.
    View in: PubMed
    Score: 0.020
  48. Masoudi FA, Havranek EP, Krumholz HM. The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev. 2002 Jan; 7(1):9-16.
    View in: PubMed
    Score: 0.020
  49. Strickberger SA, Conti J, Daoud EG, Havranek E, Mehra MR, Pi?a IL, Young J. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation. 2005 Apr 26; 111(16):2146-50.
    View in: PubMed
    Score: 0.006
  50. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002 Mar 19; 105(11):1348-53.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)